Vanda Pharmaceuticals | Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Akebia Therapeutics USD 133.38M 14.66M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
AstraZeneca USD 34.05B 518M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Enanta Pharmaceuticals USD 48.56M 4.01M 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Insmed USD 417.21M 105.53M 2025-09
J&J USD 50.87B 3.31B 2025-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.67M 143K 2025-09
Moderna USD 1.68B 109M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 117.87M 3.62M 2025-09
Veracyte USD 72.15M 4.28M 2025-09


Vanda Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.